MX2020004518A - Suministro asistido de manera magnética al interior y a través de la piel. - Google Patents
Suministro asistido de manera magnética al interior y a través de la piel.Info
- Publication number
- MX2020004518A MX2020004518A MX2020004518A MX2020004518A MX2020004518A MX 2020004518 A MX2020004518 A MX 2020004518A MX 2020004518 A MX2020004518 A MX 2020004518A MX 2020004518 A MX2020004518 A MX 2020004518A MX 2020004518 A MX2020004518 A MX 2020004518A
- Authority
- MX
- Mexico
- Prior art keywords
- skin
- magnetically
- assisted delivery
- patient
- directing
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M35/00—Devices for applying media, e.g. remedies, on the human body
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N2/00—Magnetotherapy
- A61N2/002—Magnetotherapy in combination with another treatment
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N2/00—Magnetotherapy
- A61N2/06—Magnetotherapy using magnetic fields produced by permanent magnets
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
- A61M2037/0007—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin having means for enhancing the permeation of substances through the epidermis, e.g. using suction or depression, electric or magnetic fields, sound waves or chemical agents
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Biomedical Technology (AREA)
- Public Health (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Heart & Thoracic Surgery (AREA)
- Hematology (AREA)
- Anesthesiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Radiology & Medical Imaging (AREA)
- Dermatology (AREA)
- Medical Informatics (AREA)
- Vascular Medicine (AREA)
- Medicinal Preparation (AREA)
- Media Introduction/Drainage Providing Device (AREA)
- Magnetic Treatment Devices (AREA)
Abstract
Un procedimiento para tratar a un paciente incluye proporcionar un dispositivo de suministro que pueda generar un campo magnético, colocar el dispositivo encima o debajo de la piel y dirigir el agente al interior de la piel del paciente a través del dispositivo. El agente terapéutico se dirige a un sitio de tratamiento a través de la piel. Aquí también se incluyen sistemas para dirigir agentes.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201762579544P | 2017-10-31 | 2017-10-31 | |
PCT/US2018/058572 WO2019089843A1 (en) | 2017-10-31 | 2018-10-31 | Magnetically-assisted delivery into and through the skin |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2020004518A true MX2020004518A (es) | 2020-11-11 |
Family
ID=66333345
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2020004518A MX2020004518A (es) | 2017-10-31 | 2018-10-31 | Suministro asistido de manera magnética al interior y a través de la piel. |
Country Status (6)
Country | Link |
---|---|
US (2) | US11717696B2 (es) |
EP (1) | EP3703805A4 (es) |
JP (2) | JP2021501037A (es) |
CA (1) | CA3081332A1 (es) |
MX (1) | MX2020004518A (es) |
WO (1) | WO2019089843A1 (es) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP4292660A1 (de) * | 2022-06-13 | 2023-12-20 | Fortis GmbH | System zur verabreichung eines wirkstoffs |
Family Cites Families (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IE54286B1 (en) * | 1983-01-18 | 1989-08-16 | Elan Corp Plc | Drug delivery device |
US4597961A (en) * | 1985-01-23 | 1986-07-01 | Etscorn Frank T | Transcutaneous application of nicotine |
DE3844247A1 (de) | 1988-12-29 | 1990-07-12 | Minnesota Mining & Mfg | Vorrichtung, insbesondere pflaster zum transdermalen verabreichen eines medikaments |
US6041253A (en) * | 1995-12-18 | 2000-03-21 | Massachusetts Institute Of Technology | Effect of electric field and ultrasound for transdermal drug delivery |
US6617153B2 (en) | 2000-12-05 | 2003-09-09 | Adelheid Kuehnle | Portable magneto-mechanical delivery device and method for delivery of reactive substances |
JP4809062B2 (ja) * | 2004-01-30 | 2011-11-02 | 久光製薬株式会社 | カバー材及びカバー材付き貼付剤 |
DE102007028777A1 (de) | 2007-06-22 | 2008-12-24 | Carl Zeiss Meditec Ag | Transportvorrichtung |
WO2009046345A1 (en) * | 2007-10-05 | 2009-04-09 | Worthington, W. Bradley | Magnetophoresis apparatus and method of use |
WO2009070282A1 (en) * | 2007-11-26 | 2009-06-04 | Stc.Unm | Active nanoparticles and method of using |
US8579787B2 (en) | 2008-05-19 | 2013-11-12 | University Of Maryland College Park | Methods and systems for using therapeutic, diagnostic or prophylactic magnetic agents |
US8316862B2 (en) | 2009-02-25 | 2012-11-27 | University Of Maryland | Devices, systems and methods for magnetic-assisted therapeutic agent delivery |
US10576295B2 (en) * | 2009-02-25 | 2020-03-03 | University Of Maryland | Device and methods for directing agents to the middle ear and the inner ear |
US20110060320A1 (en) | 2009-09-07 | 2011-03-10 | Chen Aharon-Attar | System and method for repairing tissue sections |
JP6046609B2 (ja) * | 2010-06-17 | 2016-12-21 | インターナショナル・サイエンティフィック・プロプライエタリー・リミテッド | 皮膚ケア製品の送達 |
AU2013212528B2 (en) * | 2012-01-24 | 2017-10-05 | International Scientific Pty Ltd | Delivery device |
ES2813365T3 (es) * | 2013-06-26 | 2021-03-23 | Univ Maryland | Sistema para dirigir agentes hacia dentro de un ojo |
EP3166648A4 (en) * | 2014-07-08 | 2018-05-30 | University of Maryland, Baltimore | Compositions and delivery methods for treating dental infections, inflammation, sensitivity, and for use in dental restorations |
BR112017000313A2 (pt) | 2014-07-11 | 2017-10-31 | Koninklijke Philips Nv | sistema para o fornecimento de uma composição para tratamento bucal, composição para tratamento bucal, método para administrar uma composição para tratamento bucal |
DK3212106T3 (da) * | 2014-10-30 | 2020-03-16 | Otomagnetics Llc | Magnetisk injektion af terapeutiske midler ved tilførsel af materialeekstruderinger med forskellig magnetisering og magnetisk permeabilitet |
CN110446491A (zh) * | 2017-03-24 | 2019-11-12 | 伊英克加利福尼亚有限责任公司 | 调节活性物质给予速率的包含带电粒子或磁性粒子的微单元递送系统 |
-
2018
- 2018-10-31 MX MX2020004518A patent/MX2020004518A/es unknown
- 2018-10-31 CA CA3081332A patent/CA3081332A1/en active Pending
- 2018-10-31 WO PCT/US2018/058572 patent/WO2019089843A1/en unknown
- 2018-10-31 EP EP18871946.2A patent/EP3703805A4/en active Pending
- 2018-10-31 US US16/760,840 patent/US11717696B2/en active Active
- 2018-10-31 JP JP2020543730A patent/JP2021501037A/ja active Pending
-
2023
- 2023-04-27 JP JP2023073309A patent/JP2023099101A/ja active Pending
- 2023-06-07 US US18/206,783 patent/US20240082594A1/en active Pending
Also Published As
Publication number | Publication date |
---|---|
WO2019089843A1 (en) | 2019-05-09 |
US11717696B2 (en) | 2023-08-08 |
JP2023099101A (ja) | 2023-07-11 |
CA3081332A1 (en) | 2019-05-09 |
US20210213299A1 (en) | 2021-07-15 |
US20240082594A1 (en) | 2024-03-14 |
EP3703805A4 (en) | 2021-07-28 |
EP3703805A1 (en) | 2020-09-09 |
JP2021501037A (ja) | 2021-01-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2015011296A (es) | Dispositivo foto-terapeutico, metodo y uso. | |
MX2022000270A (es) | Dispositivo para el suministro de una composicion para el cuidado de la piel. | |
MX2022001075A (es) | Compuestos para usarse en el tratamiento de cancer de mama que expresa el receptor de androgenos (ar+). | |
MX2022008868A (es) | Tratamiento del cancer con tg02. | |
MX2023001527A (es) | Compuestos con actividad inductora de ferroptosis y metodos de uso de estos. | |
BR112018069044A2 (pt) | dispositivo de plasma frio para tratamento da pele | |
BR112017017448A2 (pt) | métodos e composições para o tratamento de doença do olho ressecado e outros distúrbios do olho | |
MX2019009227A (es) | Métodos para tratar cáncer con inhibidores de hsp90. | |
BR112015026297A2 (pt) | terapia combinada composta por um inibidor tor quinase e um composto de 5-quinazolinona substituído para o tratamento de câncer | |
AR112102A1 (es) | Tinostamustina para utilizar en el tratamiento de cáncer de ovario | |
MX2019015212A (es) | Compuestos para el tratamiento del sarcoma. | |
JOP20190056B1 (ar) | مركبات للاستخدام في علاج القصور الكلوي الحاد | |
CL2019000846A1 (es) | Proteína terapéutica. | |
MX2018000262A (es) | Usos terapeuticos de formulaciones de berberina. | |
PH12020551179A1 (en) | Methods for treating mitochondrial disorder | |
AR103118A1 (es) | Tratamientos médicos basados en anamorelina | |
MX2020004518A (es) | Suministro asistido de manera magnética al interior y a través de la piel. | |
EA202090266A1 (ru) | Ингибиторы mpo для применения в медицине | |
SE1500342A1 (en) | New bandage | |
MX2017006227A (es) | Sistema de administración de óxido nítrico y métodos de uso. | |
NZ756307A (en) | Formulations of cannabinoids for the treatment of acne | |
PL423672A1 (pl) | Kompozycja farmaceutyczna zawierająca zebularynę oraz środek leczniczy do regeneracji ran | |
ZA202006986B (en) | Dantrolene formulations and methods of their use | |
PH12020551185A1 (en) | Nemolizumab in the treatment of atopic dermatitis with moderate to severe excoriation | |
UA126148U (uk) | Спосіб лікування періімплантного мукозиту |